EORTC at ESTRO37 Congress
19 Apr 2018
Joint ESTRO-EORTC interdisciplinary Session
Tuesday, April 24th, 09:15-10:30, Room 116
On the occasion of ESTRO 37 congress held in Barcelona from 20 to 24 April, ESTRO and EORTC have compiled a session to explore current and further future cooperation between the two organisations. The session will discuss the state of the art and future perspectives of clinical research in radiation oncology.
The focus will be on three main topics:
Oligometastatic disease:
- Is oligometastatic disease a distinct biological entity?
- Prospective trials vs registry trial in this disease
- Presentation of ESTRO-EORTC Oligocare project
Chemotherapy-beam combinations:
- General principles of association
- Challenges in conducting chemo-radiotherapy trials
- PARP inhibition and radiotherapy
and particle therapy:
- Current developments in Europe
- Discussion on the lack of level I evidence supporting this costly treatment modality and how this should be corrected by performing appropriate clinical research
More info about the joint session here.
EORTC Abstracts at ESTRO 37
EORTC will also be presenting a number of studies at the congress:
- ORAL PRESENTATION: Phase-II parallel non-randomized/observation study (EORTC 22042-26042) for non-benign meningiomas
D.C. Weber, C. Ares, S. Villa, S.M. Peerdeman, L. Renard, B.G. Baumert, A. Lucas, J.J. Stelmes, S. Collette, R. Miralbell OC-0589
Presented at 16h35 in the Auditorium on Monday 23 April 2018 - POSTER PRESENTATION: PV-0200: Benchmark Case results from the EORTC Lungtech trial of SBRT for patients with centrally NSCLC
M. Lambrecht, E. Clementel, J. Sonke, U. Nestle, S. Adebahr, M. Guckenberger, D. Weber, C. Hurkmans.
Presented Saturday, April 21st, 16:15 – 17:30, Poster area, candidate for best poster in the track. - POSTER PRESENTATION: Quality assurance of radiotherapy in the EORTC 1420 Best-of trial. Preliminary results
J.J. Stelmes (Belgium), E. Clementel, J. Kaźmierska, M. Ozsahin, M. Tomsej, L. Viellevigne, V. Gregoire, C. Hurkmans, N. Andratschke, D.C. Weber PO-0708
Find the Abstracts Book of ESTRO 37 here.
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023